gabapentin
Vérifier sur tripsit
Gabapentin
Vérifier sur psychonaut
Gabapentin
Vérifier sur isomerdesign
Gabapentin
Vérifier sur pubchem
Gabapentine
Vérifier sur druglab
Gabapentin
Vérifier sur drugmap
Gabapentin
Vérifier sur wiki
Data
InChI: InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)
Synonymes: HMS2236O03, 1-(Aminomethyl)-cyclohexaneacetic acid,GABAPENTIN [EP MONOGRAPH],SBI-0206904.P001, Novo-Gabapentin, Vultin, Gabapentinum,GABAPENTIN [VANDF],Tocris-0806, Goe-3450,CCG-204671,Serada,6CW7F3G59X,GABAPENTIN [JAN],DTXSID0020074, Apo-Gabapentin, Gabapentin-ratiopharm,Gabapentin (JAN/USP/INN),GABAPENTIN [ORANGE BOOK],GBN,SPBio_002822,1-aminomethyl-1-cyclohexane-acetic acid,Gabapentin, Pharmaceutical Secondary Standard; Certified Reference Material,1-aminomethylcyclohexane acetic acid,CHEBI:42797,EINECS 262-076-3,Neurontin (TN), Gabapentine [INN-French], Aventis brand of gabapentin,NCGC00015466-05,gabapentin,NSC-759254,Gabapentin,GABAPENTIN [INN],BCP25698, 1-(Aminomethyl)cyclohexaneacetic acid,BRN 2359739,GOE 3450,DSSTox_CID_74, Stadapharm brand of gabapentin,Prestwick0_000861,(1-Aminomethyl-cyclohexyl)-acetic acid,Gabapentin-D10,Aclonium, 2-[1-(aminomethyl)cyclohexyl]acetic acid,CHEMBL940,DSSTox_GSID_20074,GABAPENTIN [MART.],Novo-Gabapentine, Parke Davis brand of gabapentin,Neurontin,Cyclohexaneacetic acid, 1-(aminomethyl)-,NCGC00015466-04,1-(Aminomethyl)cyclohexaneacetic acid, Gabapentino,BPBio1_000993,HY-A0057,BSPBio_000901,Gabapentin solution,NCGC00015466-27,neurontin,CARBATIN,Gabapentin-ER, Gabapentin [USAN:INN:BAN],Prestwick3_000861,CI 945, Gabapentin GR,DDS-2003, Gabapentinum [INN-Latin], Pfizer brand of gabapentin,Gralise,NCGC00021545-04,SCHEMBL8343, Pharmascience brand of gabapentin,NCGC00015466-02,C07018,Z336079954,GABAPENTIN [HSDB], DM-5689,SR-01000000019-11, Gabapentine,NCGC00021545-05,Q410352,gabapentin (Neurontin),Gabapentin GR,EN300-52516,60142-96-3,1-(Aminomethyl)-cyclohexaneacetic acid, Gabapentin (Neurontin), GBN,Fanatrex,CCRIS 7210,AM20070538,1-(aminomethyl)cyclohexanacetic acid,GABAPENTIN [USP-RS],1-aminomethyl cyclohexaneacetic acid,2-(1-(aminomethyl)cyclohexyl)acetic acid,Therapentin-90,Vultin,Neuontin,1-Aminomethyl-1cyclohexane-acetic acid,Gabapentine,Acetic acid,2-[1-(aminomethyl)cyclohexyl], Neurontin (TN),Prestwick1_000861,KS-1064,NSC 759254,Lopac0_000582,GABAPENTIN [USP MONOGRAPH],Gabapentinum [INN-Latin], Gabapentin Hexal,GABAPENTIN [EP IMPURITY],Gabapentin, European Pharmacopoeia (EP) Reference Standard,Gabapentino [INN-Spanish], [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID,FT-0626586,1126623-20-8,NCGC00015466-07, Gabapetin, Serada,42G963,NCGC00021545-02,Tox21_110157,[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID,AB07485,Tox21_110157_1,HMS2089J03,NCGC00015466-11,Gabapentin [USAN:USP:INN:BAN],CAS-60142-96-3,Gabapentine [INN-French],GABAPETINE,1-(Aminomethyl)cyclohexaneaceticAcid,Prestwick2_000861,DM-5689,Gabapentin 100 microg/mL in Acetonitrile:Methanol,BBL010794,LP00582,GOE 2450,HMS3261F06,1-(aminomethyl)cyclohexyl-acetic Acid,GABAPENTIN [MI], Apotex brand of gabapentin,MFCD00865286,D00332,BDBM50080153,NCGC00015466-08,SDCCGSBI-0050564.P002, GOE 2450,NCGC00015466-09,ZINC4949,Lopac-G-154,Gabapentino,UNII-6CW7F3G59X, Gabapentin Stada,FT-0668920,HMS2097N03, Gabapen, Warner-Lambert brand of gabapentin,Gabapentinum,NCGC00015466-06, DDS-2003,SR-01000000019, Gabapentino [INN-Spanish],NCGC00016891-01, Hexal brand of gabapentin,MLS000069358,NSC742194, Gabapentinium,SMR000058311,Gabapentin, United States Pharmacopeia (USP) Reference Standard,GTPL5483,HMS1570N03,Z1258578343,DM-1796, DM-1796,GABAPENTIN [USAN],HSDB 7364,AKOS000280865,HMS3650A20,SR-01000000019-6,ACT03340,Gabapen,Gabapentin solution, 10 mg/mL in methanol, ampule of 1 mL, certified reference material,1-amino methyl cyclohexane-acetic acid,G-154,Sefelsa,DSSTox_RID_75350,gabapentina,Gabapentin, solid,STK598009, PMS-Gabapentin,HMS3714N03,Tox21_500582,Gabapentin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Ratiopharm brand of gabapentin,CS-1545,NCGC00015466-03, Neurontin, G-154,Gabarone,NSC-742194,GABAPENTIN [WHO-DD], Gabapentina,SR-01000000019-2, Gabapentin (JAN/USAN/INN),Go 3450,DB00996,NCGC00015466-01,GABAPENTIN; NEURONTIN,BIDD:GT0656, Gabapentino [Spanish],NSC 742194,Gabapentino [Spanish],Prestwick_151,DTXCID5074,AC-1485,CI-945,Goe-3450,Gralise (TN),NCGC00261267-01,G0318,s2133, Go 3450,2-[1-(aminomethyl)cyclohexyl]acetic acid,gabapentinium,C9H17NO2,Gabapetin,EU-0100582, Novopharm brand of gabapentin,L000733,Neurentin
Estimated data
Solubility: -0.791 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 61.5% (prediction based on www.mdpi.com)
